7% Off
Itokine50 mg
Everest Pharmaceuticals Ltd.
৳83.70
Add to cart
Best PriceTk 46.00/10's Strip
1
Alternatives
Price
Medicine overview
Indications of Itopa-50 50 mg
Itopa-50 50 mg is indicated for the treatment of functional gastrointestinal motility disorders and symptoms associated with impaired gastric emptying.
It is commonly used for:
- Chronic gastritis-related symptoms such as bloating, upper abdominal pain, nausea, vomiting, and heartburn
- Functional dyspepsia (non-ulcer dyspepsia) including early satiety and postprandial fullness
- Delayed gastric emptying (gastroparesis-like symptoms)
- Upper gastrointestinal discomfort associated with poor gastric motility
Itopa-50 50 mg helps improve gastric motility and reduces symptoms of indigestion by enhancing coordinated stomach and intestinal movement.
Pharmacology
Itopa-50 50 mg is a prokinetic agent that acts through dual mechanisms: dopamine D2 receptor antagonism and acetylcholinesterase (AChE) inhibition. By blocking dopamine D2 receptors and inhibiting the breakdown of acetylcholine, it increases acetylcholine availability in the gastrointestinal tract.
The increased acetylcholine enhances gastrointestinal motility, improves gastric emptying, and strengthens gastro-duodenal coordination. It also increases lower esophageal sphincter (LES) tone, helping reduce reflux symptoms and improving overall upper GI function.
Pharmacologically, Itopride supports efficient peristalsis throughout the stomach and intestines, making it effective in conditions associated with delayed gastric motility and functional dyspepsia.
Dosage & Administration of Itopa-50 50 mg
Itopa-50 50 mg is administered orally and should be taken exactly as prescribed for optimal improvement of gastrointestinal motility symptoms.
Adult Dose:
The usual recommended dose is 50 mg three times daily, taken before meals. Dosage may be adjusted based on the patient’s age, symptom severity, and clinical response.
Elderly Patients:
Older patients may be more sensitive to adverse effects; therefore, careful monitoring is recommended. Dose reduction or discontinuation may be required if side effects occur.
Pediatric Use:
Safety and efficacy in children and adolescents under 18 years have not been established; therefore, use is not recommended in this population.
Important Safety Considerations:
- Rare cases of shock or anaphylactoid reactions may occur. If symptoms such as hypotension, dyspnea, laryngeal edema, rash, or sweating appear, discontinue immediately and initiate appropriate treatment.
- Liver function abnormalities and jaundice (elevated AST, ALT, γ-GTP) may occur; regular monitoring is advised and treatment should be stopped if significant abnormalities develop.
General advice:
Itopride should preferably be taken before meals to enhance gastric motility and improve therapeutic effectiveness.
Interaction of Itopa-50 50 mg
Itopa-50 50 mg should be used with caution when administered with drugs that affect gastrointestinal motility, particularly anticholinergic agents.
With medicines:
- Anticholinergic drugs (e.g., Tiquizium bromide, Scopolamine butyl bromide, Timepidium bromide): May reduce the prokinetic effect of Itopride by inhibiting gastrointestinal motility. This can decrease its therapeutic effectiveness in improving gastric emptying and digestive symptoms.
Mechanism of interaction:
Anticholinergic agents reduce acetylcholine-mediated gastrointestinal activity, which directly opposes the cholinergic-enhancing action of Itopride. As a result, the motility-stimulating effect of Itopride may be diminished.
Clinical advice:
Concurrent use should be avoided or carefully monitored, and alternative therapies should be considered if possible to ensure optimal gastrointestinal benefit.
Contraindications
Itopa-50 50 mg is contraindicated in patients where its use may cause harm or where hypersensitivity reactions are present.
Contraindications include:
- Hypersensitivity: Known allergy to Itopride or any of the excipients in the formulation.
- Gastrointestinal obstruction: Mechanical obstruction of the stomach or intestines where increased motility may worsen the condition.
- Gastrointestinal hemorrhage: Active GI bleeding where stimulation of motility is contraindicated.
- Gastrointestinal perforation: Suspected or confirmed perforation of the GI tract.
Itopride should only be used under medical supervision and avoided in conditions where enhanced gastrointestinal motility may pose a risk.
Pregnancy & Lactation
Itopa-50 50 mg should be used with caution during pregnancy and lactation due to limited human safety data.
Pregnancy:
Safety in pregnant women has not been well established. It should only be used during pregnancy if the expected therapeutic benefit clearly outweighs the potential risk to the mother and fetus.
Lactation (Breastfeeding):
Data on excretion into human breast milk are insufficient. Animal studies suggest possible transfer into milk; therefore, Itopride is not recommended during breastfeeding unless advised by a physician after careful risk–benefit evaluation.
Precautions & Warnings
Itopa-50 50 mg should be used carefully due to its action on gastrointestinal motility through cholinergic pathways.
Key precautions include:
- Cholinergic activity: Itopride enhances acetylcholine action; therefore, it should be used with caution in patients sensitive to increased gastrointestinal motility.
- Lack of response: If no improvement in gastrointestinal symptoms is observed after a reasonable treatment period, long-term continuous use should be avoided.
- Proper use of packaging (PTP warning): Tablets packaged in press-through packs (PTP) must be removed before ingestion. Accidental swallowing of the PTP material may cause serious injury such as esophageal mucosal damage, perforation, or mediastinal complications.
- General safety advice: Patients should follow prescribed dosing strictly and avoid prolonged unsupervised use.
Overall warning:
Itopride should be used under medical supervision, ensuring proper duration of therapy and safe handling of dosage forms to prevent accidental injury.
Overdose Effects of Itopa-50 50 mg
In case of excessive overdose, the usual measures of gastric lavage and symptomatic therapy should be applied.
Storage Conditions
Store below 30°C, in a cool and dry place. Keep away from light. Keep all the medicine out of the reach of children.
Frequently Asked Questions
What is Itopa-50 50 mg used for?
Itopa-50 50 mg is indicated for the treatment of functional gastrointestinal motility disorders and symptoms associated with impaired gastric emptying. It is commonly used for: Chronic gastritis-related symptoms such as bloating, upper abdominal pain, nausea, vomiting, and heartburn Functional dyspepsia (non-ulcer dyspepsia) including early satiety and postprandial fullness Delayed gastric emptyin…
What is the dosage of Itopa-50 50 mg?
Itopa-50 50 mg is administered orally and should be taken exactly as prescribed for optimal improvement of gastrointestinal motility symptoms. Adult Dose: The usual recommended dose is 50 mg three times daily , taken before meals. Dosage may be adjusted based on the patients age, symptom severity, and clinical response. Elderly Patients: Older patients may be more sensitive to adverse effects; the…
Who should not take Itopa-50 50 mg?
Itopa-50 50 mg is contraindicated in patients where its use may cause harm or where hypersensitivity reactions are present. Contraindications include: Hypersensitivity: Known allergy to Itopride or any of the excipients in the formulation. Gastrointestinal obstruction: Mechanical obstruction of the stomach or intestines where increased motility may worsen the condition. Gastrointestinal hemorrhage…
What precautions should be taken with Itopa-50 50 mg?
Itopa-50 50 mg should be used carefully due to its action on gastrointestinal motility through cholinergic pathways. Key precautions include: Cholinergic activity: Itopride enhances acetylcholine action; therefore, it should be used with caution in patients sensitive to increased gastrointestinal motility. Lack of response: If no improvement in gastrointestinal symptoms is observed after a reasona…
Is Itopa-50 50 mg safe during pregnancy and breastfeeding?
Itopa-50 50 mg should be used with caution during pregnancy and lactation due to limited human safety data. Pregnancy: Safety in pregnant women has not been well established. It should only be used during pregnancy if the expected therapeutic benefit clearly outweighs the potential risk to the mother and fetus. Lactation (Breastfeeding): Data on excretion into human breast milk are insufficient. A…
Disclaimer
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.